Related references
Note: Only part of the references are listed.The Therapeutic Potential of 2-{[4-(2-methoxyphenyl) piperazin-1-yl]alkyl}-1H-benzo[d]imidazoles as Ligands for Alpha1-Adrenergic Receptor - Comparative In Silico and In Vitro Study
Jelena Z. Penjisevic et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2022)
MicroRNA miR-133a-3p Facilitates Adrenergic Proarrhythmic Ectopy in Rat Pulmonary Vein Myocardium by Increasing cAMP Content
V. S. Kuz'min et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2022)
A Concise and Useful Guide to Understand How Alpha1 Adrenoceptor Antagonists Work
Sidiane B. da Silva et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2022)
α1-adrenergic receptors accompanied by GATA4 expression are related to proarrhythmic conduction and automaticity in rat interatrial septum
Ksenia B. Pustovit et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2022)
Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs
John Larson et al.
JOURNAL OF CLINICAL MEDICINE (2022)
The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α1-Adrenolytic Properties
Klaudia Lustyk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Role of α1-blockers in the current management of hypertension
Hua Li et al.
JOURNAL OF CLINICAL HYPERTENSION (2022)
HBK-10, A Compound with α1-Adrenolytic Properties, Showed Antiarrhythmic and Hypotensive Effects in Rats
Klaudia Lustyk et al.
PHARMACEUTICALS (2022)
Attenuation of inward rectifier potassium current contributes to the α1-adrenergic receptor-induced proarrhythmicity in the caval vein myocardium
Alexandra D. Ivanova et al.
ACTA PHYSIOLOGICA (2021)
Cardiac α1A-adrenergic receptors: emerging protective roles in cardiovascular diseases
Jiandong Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2021)
Cardiac macrophages prevent sudden death during heart stress
Junichi Sugita et al.
NATURE COMMUNICATIONS (2021)
Amiodarone: A Comprehensive Guide for Clinicians
David Hamilton Sr et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2020)
Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension
Rachel D. Savage et al.
JAMA INTERNAL MEDICINE (2020)
Editorial: Perspectives of Antiarrhythmic Drug Therapy: Disappointing Past, Current Efforts, and Faint Hopes
Peter P. Nanasi et al.
FRONTIERS IN PHARMACOLOGY (2020)
Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
Meng Geng et al.
FRONTIERS IN PHARMACOLOGY (2020)
Antiarrhythmic Drugs Check lot Risks and Benefits
Pranav Mankad et al.
MEDICAL CLINICS OF NORTH AMERICA (2019)
Hopes and disappointments with antiarrhythmic drugs
A. John Camm
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Synthesis and Pharmacological Activity of a New Series of 1-(1H-Indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol Analogs
Marek Bednarski et al.
ARCHIV DER PHARMAZIE (2016)
Cardiac arrhythmia classification using statistical and mixture modeling features of ECG signals
Rashid Ghorbani Afkhami et al.
PATTERN RECOGNITION LETTERS (2016)
Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats
Karolina Pytka et al.
FRONTIERS IN PHARMACOLOGY (2016)
α-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one
Paula Zareba et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Cardiac late Na+ current: Proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress
Luiz Belardinelli et al.
HEART RHYTHM (2015)
Biofunctional studies of new 2-methoxyphenylpiperazine xanthone derivatives with α1-adrenolytic properties
Anna Rapacz et al.
PHARMACOLOGICAL REPORTS (2015)
The hypotensive activity and alpha1-adrenoceptor antagonistic properties of some aroxyalkyl derivatives of 2-methoxyphenylpiperazine
Monika Kubacka et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Synthesis and SAR-study for novel arylpiperazine derivatives of 5-arylidenehydantoin with α1-adrenoceptor antagonistic properties
Jadwiga Handzlik et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Antiarrhythmic Drug Therapy for Atrial Fibrillation
Peter Zimetbaum
CIRCULATION (2012)
Pharmacophore models based studies on the affinity and selectivity toward 5-HT1A with reference to α1-radrenergic receptors among arylpiperazine derivatives of phenytoin
Jadwiga Handzlik et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Evaluation of 1-Arylpiperazine Derivative of Hydroxybenzamides as 5-HT1A and 5-HT7 Serotonin Receptor Ligands: An Experimental and Molecular Modeling Approach
Piotr Kowalski et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2011)
The paradox of α-adrenergic coronary vasoconstriction revisited
Gerd Heusch
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties
Jacek Sapa et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Synthesis and Adrenolytic Activity of New Propanolamines
Grazyna Groszek et al.
MOLECULES (2010)
α1-Adrenergic Receptor Subtypes in Nonfailing and Failing Human Myocardium
Brian C. Jensen et al.
CIRCULATION-HEART FAILURE (2009)
Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1
Grazyna Groszek et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol analogs and its enantiomers. Part 2
Grazyna Groszek et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
α-adrenoceptor blockade modifies neurally induced atrial arrhythmias
Louis-Philippe Richer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Effect of acute alpha adrenergic stimulation on cardiac function
Stacy Dunaway et al.
PERFUSION-UK (2007)
The role of adrenergic receptor polymorphisms in heart failure
A. Biolo et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C - Electrophysiological, anti-adrenergic, and anti-angiotensin II effects
P Gautier et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Adrenergic regulation of the rapid component of the cardiac delayed rectifier potassium current, IKr, and the underlying hERG ion channel
D Thomas et al.
BASIC RESEARCH IN CARDIOLOGY (2004)
Sympathetic nervous system activity and ventricular tachyarrhythmias: Recent advances
KP Anderson
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY (2003)
In vivo measurement of OT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity
F De Clerck et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2002)
Drug-induced proarrhythmic effects: assessment of changes in QT interval
DJ Sheridan
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
